Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1531 AL 1545

Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease

Abbruzzese G, Antonini A, Barone P, Stocchi F, Tamburini T, Bernardi L, Amboni M, Vacca L, Posocco V, Colombo D.

Neurol Sci. 2012 Dec;33(6):1319-27. doi: 10.1007/s10072-012-0943-y. Epub 2012 Feb 4.

Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs

Joubert J, Geldenhuys WJ, Van der Schyf CJ, Oliver DW, Kruger HG, Govender T, Malan SF.

ChemMedChem. 2012 Mar 5;7(3):375-84. doi: 10.1002/cmdc.201100559. Epub 2012 Feb 3.

Pseudo-heterozygous rearrangement mutation of parkin

Funayama M, Yoshino H, Li Y, Kusaka H, Tomiyama H, Hattori N.

Mov Disord. 2012 Apr;27(4):552-5. doi: 10.1002/mds.24906. Epub 2012 Feb 5.

Concurrent Koro and Cotard syndromes in a Spanish male patient with a psychotic depression and cerebrovascular disease

Alvarez P, Puente VM, Blasco MJ, Salgado P, Merino A, Bulbena A.

Psychopathology. 2012;45(2):126-9. doi: 10.1159/000329739. Epub 2012 Feb 4.

Echogenicity of the substantia nigra region in Parkinson's disease

Bor-Seng-Shu E, Almeida KJ, Andrade DC, Fonoff ET, Teixeira MJ, Barbosa ER.

Arq Neuropsiquiatr. 2012 Feb;70(2):153-4. doi: 10.1590/s0004-282x2012000200016.

Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression

Wand AP.

Aust N Z J Psychiatry. 2012 Feb;46(2):178. doi: 10.1177/0004867411433221.

Clinical inquiry. Which drugs work best for early Parkinson's disease?

Jain L, Benko R, Safranek S.

J Fam Pract. 2012 Feb;61(2):106-8.

Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson's disease

Ravid R, Ferrer I.

FEBS J. 2012 Apr;279(7):1167-76. doi: 10.1111/j.1742-4658.2012.08518.x. Epub 2012 Feb 28.

Cellular models to investigate biochemical pathways in Parkinson's disease

Alberio T, Lopiano L, Fasano M.

FEBS J. 2012 Apr;279(7):1146-55. doi: 10.1111/j.1742-4658.2012.08516.x. Epub 2012 Feb 28.

Postmortem observation of collagenous lead tip region fibrosis as a rare complication of DBS

Vedam-Mai V, Yachnis A, Ullman M, Javedan SP, Okun MS.

Mov Disord. 2012 Apr;27(4):565-9. doi: 10.1002/mds.24916. Epub 2012 Feb 7.

Comparison of enrollees and decliners of Parkinson disease sham surgery trials

Kim SY, Wilson RM, Kim HM, Holloway RG, De Vries RG, Frank SA, Kieburtz K.

Mov Disord. 2012 Apr;27(4):506-11. doi: 10.1002/mds.24940. Epub 2012 Feb 7.

Genetics of Parkinson's disease

Klein C, Westenberger A.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a008888. doi: 10.1101/cshperspect.a008888.

Inflammation and adaptive immunity in Parkinson's disease

Mosley RL, Hutter-Saunders JA, Stone DK, Gendelman HE.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.

Tai chi and postural stability in patients with Parkinson's disease

Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, Maddalozzo G, Batya SS.

N Engl J Med. 2012 Feb 9;366(6):511-9. doi: 10.1056/NEJMoa1107911.

Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial

Rascol O, Bronzova J, Hauser RA, Lang AE, Sampaio C, Theeuwes A, van de Witte SV.

Parkinsonism Relat Disord. 2012 May;18(4):370-6. doi: 10.1016/j.parkreldis.2011.12.006. Epub 2012 Feb 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias